The rapid advances in radiation oncology, radiation biology, and radiation therapy physics have led to an accumulation of information on the interactions of radiation with other therapeutic modalities, such as the wide array of chemotherapeutic agents being employed in combination with radiation therapy, as well as the multiple biologic response modi? ers that are being used in combination with radiation therapy. It is now recognized that they have a signi? cant impact on normal tissue toxicities. The radiation doses customarily deemed safe on the basis of past experience have now, when combined with other modalities, led to severe late effects in different vital organs. The previously de? ned radiation tolerance dosages remain as valuable guides, but their applicability has changed signi? cantly. The emphasis is now placed on the volume of the organ irradiated, as well as the dose being used. New constructs rel- ing global (whole organ) and focal (partial volume) injury as a function of the dose volume histogram emerge as a signi? cant predictor of late effects on normal tissues. There are now mathematical models such as the model on standard dose, time-dose factors, and accumulated radiation effects that have been supplanted by linear-q- dratic equations using the alpha/beta ratio and its clinical applicability to normal tissue complications. This volume presents contemporary data relating to late effects on normal tissues.

Radiation (and Medical) Biosurveillance

Medical Countermeasures to Radiation Injury
Ionizing Radiation and the Endothelium
Inflammation and Cell Adhesion Molecules are Involved in Radiation-Induced Lung Injury
Volume Effects in Radiation Damage to Rat Lung
The Role of Imaging in the Study of Radiation-Induced Normal Tissue Injury
Screening for Cardiovascular Disease in Survivors of Thoracic Radiation
Hypoxia-Mediated Chronic Normal Tissue Injury
Prevention and Treatment of Radiation Injuries
Second Malignancies as a Consequence of Radiation Therapy
Using Quality of Life Information to Rationally
Cancer-Related Fatigue as a Late Effect:
Normal Tissue TNM Toxicity Taxonomy
Cancer Survivorship Research:.